AnnKatrin Petersen

In Vitro Antiviral Activity and Single-Dose Pharmacokinetics in Humans of a Novel, Orally Bioavailable Inhibitor of Human Rhinovirus 3C Protease

Amy K. Patick, Mary A. Brothers, Fausto Maldonado et al. · Antimicrobial Agents and Chemotherapy · 2005 · 135 citations

Medicine, Pharmacokinetics, Pharmacology +17

Ozanimod in Patients With Moderate to Severe Ulcerative Colitis Naive to Advanced Therapies

Bruce E. Sands, Geert D’Haens, Remo Panaccione et al. · Clinical Gastroenterology and Hepatology · 2024 · 22 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +12

Greater Reversal of CD4 ⁺ Cell Abnormalities and Viral Load Reduction after Initiation of Antiretroviral Therapy with Zidovudine, Lamivudine, and Nelfinavir before Complete HIV Type 1 Seroconversion

Don Smith, Gilbert R. Kaufmann, James O. Kahn et al. · AIDS Research and Human Retroviruses · 2003 · 12 citations

Pharmacy, Infectious Diseases, Pharmacotherapy +15

Pharmacokinetics of Nelfinavir in Subjects With Hepatic Impairment

Bharat Damle, Dial Hewlett, Poe‐Hirr Hsyu et al. · The Journal of Clinical Pharmacology · 2006 · 12 citations

Pharmacy, Pharmacokinetics, Pharmacology +17

P031 Impact of Prior Biologic Exposure on Response to Ozanimod for Moderate-to-Severe Ulcerative Colitis in the Phase 3 True North Study

Bruce E. Sands, Marc Pondel, Michael Silver et al. · The American Journal of Gastroenterology · 2021 · 12 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +17